Independent educational platform dedicated to medication access research, pharmaceutical policy awareness, and public health education.
Accurate health information
for life-changing treatment decisions
When a diagnosis arrives — HIV, Hepatitis C, a cancer diagnosis, or a weight-related condition — the information you find online can determine whether you get the right treatment, at the right time, at a cost you can manage.
“Patients who understand their condition and their treatment options make better decisions — and achieve better outcomes. SunnyPharma exists to close the gap between clinical evidence and what patients can actually find and understand online.”
Our editorial mission: evidence-based, clearly explained, free from commercial influence.
Four areas where correct information is critical
These are conditions where treatment decisions are complex, costs are high, and misinformation causes real harm. We publish clinician-reviewed guides so patients and caregivers can navigate each one with confidence.
Modern antiretroviral therapy can suppress HIV to undetectable levels within weeks — making transmission effectively impossible and life expectancy equivalent to the general population. But choosing the right regimen, understanding costs, and accessing assistance programs requires detailed, up-to-date information.
Hepatitis C is now curable in 95%+ of patients with 8–12 weeks of direct-acting antivirals — yet millions remain undiagnosed or untreated due to cost barriers and lack of awareness. We cover genotype-specific treatment regimens, cure rates, insurance coverage, and how to access patient assistance programs.
Cancer treatment has been transformed by targeted therapies and immunotherapy, but the landscape of options, biomarkers, and treatment lines is exceptionally complex. Our oncology content is designed to help patients understand what their diagnosis means, what questions to ask their oncologist, and how to evaluate treatment paths.
GLP-1 receptor agonists have redefined what is medically achievable in obesity treatment. With 15–22% body weight reductions now possible and strong cardiovascular benefit data, the conversation has shifted from willpower to biology. We cover the clinical evidence, candidacy criteria, and how to discuss options with a physician.
The stakes are not abstract
These conditions affect tens of millions of people in the United States alone. In every case, delays to diagnosis, incorrect treatment choices, or inability to access financial assistance lead to measurable harm.
Treatment decisions are irreversible. Choosing the wrong HIV regimen, delaying Hepatitis C treatment while fibrosis advances, or missing a cancer biomarker test that determines drug eligibility — these are not recoverable mistakes. Accurate, physician-reviewed information at the point of decision changes outcomes.
How every article is produced
SunnyPharma content follows a structured editorial process designed to meet the medical publishing standard of E-E-A-T: Experience, Expertise, Authoritativeness, and Trustworthiness.
-
1Written by qualified health communicators
Every article is written by a medical writer with clinical background or advanced training in the relevant therapeutic area — not by generalists or content mills. Authors hold credentials including CMPP certification, PhDs in life sciences, and backgrounds in clinical research or pharmacy.
-
2Reviewed by a licensed physician specialist
Each article is reviewed for clinical accuracy by a physician with specialty training in the relevant area — including board-certified infectious disease specialists, oncologists, and endocrinologists. Reviewer credentials, affiliation, and LinkedIn profile are published transparently on every page.
-
3Referenced against primary clinical evidence
Every clinical claim is referenced to its source: FDA prescribing information, published clinical trial results, DHHS treatment guidelines, AASLD guidelines, or equivalent authoritative sources. References are cited inline and listed at the end of each article.
-
4Updated to reflect current guidelines
Treatment guidelines in HIV, Hepatitis C, and oncology change regularly. SunnyPharma content is reviewed and updated when guidelines or approval status changes. Each page displays a visible last-reviewed date, and the date is tied to the structured data schema reviewed by Google.
-
5Editorially independent — no commercial influence
SunnyPharma does not accept sponsored content, affiliate placements, or advertising from pharmaceutical manufacturers. Our editorial decisions are made solely on the basis of clinical relevance and patient need. We do not sell medication.
What we commit to on every page
These are not aspirational guidelines — they are requirements applied to every article before publication.
All dosing, efficacy figures, and safety information are verified against current FDA prescribing information and published clinical trial data.
Every article carries a named, credentialed medical reviewer whose specialization is relevant to the topic. No anonymous review.
Clinical claims link to primary sources — trial publications, FDA labels, DHHS and AASLD guidelines — not secondary media reports.
No pharmaceutical advertising, no sponsored content, no affiliate commissions on medication purchases. Commercial separation is absolute.
Every page shows a visible publication date and last-reviewed date, matched to the schema markup for accurate Google indexing.
Clinical precision is non-negotiable — but so is clarity. Content is written to be understood by an informed adult without a medical degree.
Written and reviewed by specialists
Every SunnyPharma article names its author and medical reviewer. These are the people behind our content.
Our content does not constitute medical advice. SunnyPharma articles are designed to support informed conversations with your healthcare provider — not to replace them. Always consult a licensed clinician before making changes to your treatment.